https://www.selleckchem.com/pr....oducts/brigatinib-ap
t to predict prognosis, especially in IDH-mutant astrocytoma patients.We report a case of a child with severe psoriasis vulgaris that developed neutralizing anti-drug antibodies against the biologic agent adalimumab 3 months after the first administration of the drug during Streptococcus pyogenes infection of the throat. After replacement of biologic agent, she was unsuccessfully treated with etanercept. Treatment with ustekinumab was the last option and initially it also appeared ineffective, but as we shortened the interval
Like
Comment
Share
